Your account is not claimed yet. You can sign up with ORCID to claim your account.

Neeraj K Aryal (Neeraj Aryal)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Neuroendocrine Tumors

Endoplasmic Reticulum

Cell Cycle Arrest

Top Venues

Science advances

AstraZeneca R&D Boston

The University of Texas MD Anderson Cancer Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca R&D Boston Oct 29o 2018

United States

PostDoc :: Bioscience, Oncology R&D

Education History

The University of Texas MD Anderson Cancer Center Aug 24o 2011

United States

PHD :: Genetics

Publications

Scott Boiko, Theresa Proia, Maryann San Martin, Gareth P Gregory, Michelle Min Wu, Neeraj K Aryal, Maureen Hattersley, Wenlin Shao, Jamal C Saeh, Stephen E Fawell, Ricky W Johnstone, Lisa Drew, Justin Cidado
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas. Blood 137 (21) (2021)
Amanda R Wasylishen, Chang Sun, Sydney M Moyer, Yuan Qi, Gilda P Chau, Neeraj K Aryal, Florencia McAllister, Michael P Kim, Michelle Craig Barton, Jeannelyn S Estrella, Xiaoping Su, Guillermina Lozano
Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. Science advances 6 (32) (2020)